Knockdown of specific enzymes in the riboflavin biosynthesis pathway of non-typhoidal Salmonella isolates differentially controls human mucosal-associated invariant T cell activation during infection. Using comparative transcriptomic profiling of human peripheral blood mononuclear cells infected with typhoidal strains and sequence type 313 isolates, researchers observed that mucosal-associated invariant T cells mounted an immune response to typhoidal strains but did not respond to the sequence type 313 isolate D23580.
Invasive non-typhoidal Salmonella sequence type 313 isolates have emerged across sub-Saharan Africa, characterized by high rates of multidrug resistance, enhanced intracellular persistence, increased systemic dissemination, and immune evasion. Earlier research demonstrated that the sequence type 313 isolate D23580 avoids the activation of mucosal-associated invariant T cells when compared with the genetically similar, non-invasive Salmonella Typhimurium 4/74 strain, although the exact mechanism driving this difference remained unresolved.
To identify the cellular mechanisms responsible for this evasion, the investigators engineered an inducible CRISPR interference system targeting riboflavin biosynthesis enzymes, known as rib, which process ligands that stimulate mucosal-associated invariant T cells. When testing these bacterial modifications in D23580 and 4/74 strains, several rib hypomorphs demonstrated prolonged lag times in minimal media, an effect that proved substantially more pronounced in D23580 than in the 4/74 strain.
Experimental infection of human peripheral blood mononuclear cells revealed that silencing lumazine synthase, termed RibH, and riboflavin synthase, termed RibE, yielded divergent immune activation outcomes. Knockdown of RibH successfully restored mucosal-associated invariant T cell activation in D23580 without altering activation levels in 4/74. In contrast, knockdown of RibE diminished mucosal-associated invariant T cell activation by 4/74 but produced no measurable impact on activation by D23580.
Metabolomic analysis confirmed an accumulation of the biosynthetic intermediate DMRL following RibE knockdown and demonstrated differential impacts on riboflavin biosynthesis end products between D23580 and 4/74 during RibH knockdown. These findings indicate altered metabolic pathway flux between the two strains, pointing to RibH and RibE as crucial metabolic nodes that direct strain-specific mucosal-associated invariant T cell activation and highlighting the interplay between bacterial metabolism and human immune defenses.
Subject of Research: Differential regulation of human MAIT cell activation by Salmonella riboflavin biosynthesis enzymes
Article Title: Modulation of riboflavin biosynthesis enzymes in non-typhoidal Salmonella isolates differentially impacts human MAIT cell activation
Article References: Vainman, L., Kulicke, C. A., Oketade, N., Bossel Ben-Moshe, N., Ciolli-Mattioli, C., Solomon, A., Hinton, J. C. D., Dobos, K. M., Lewinsohn, D. M., Hen-Avivi, S., & Avraham, R. (2026). Modulation of riboflavin biosynthesis enzymes in non-typhoidal Salmonella isolates differentially impacts human MAIT cell activation. PLOS Pathogens, 22(11), e1014715. https://doi.org/10.1371/journal.ppat.1014715
Image Credits: AI Generated
DOI: 10.1371/journal.ppat.1014715
Keywords: Salmonella, MAIT cells, riboflavin biosynthesis, CRISPRi, RibH, RibE, bacterial metabolism, immunology, Modulation, riboflavin, biosynthesis, enzymes
News Source: Drew Townsend. (November 9, 2026). Salmonella Riboflavin Biosynthesis Enzymes Differentially Regulate Human Immune Cell Activation. Scienmag.



